Symphony Capital closes $315m funds

The New York biopharmaceutical specialist closes its first ever fund alongside a friends-and-family vehicle.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this